| Product Code: ETC11704815 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Daratumumab Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Daratumumab Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Daratumumab Market - Industry Life Cycle |
3.4 Thailand Daratumumab Market - Porter's Five Forces |
3.5 Thailand Daratumumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Thailand Daratumumab Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Thailand Daratumumab Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Thailand Daratumumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand Daratumumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple myeloma in Thailand |
4.2.2 Growing awareness about the benefits of daratumumab therapy |
4.2.3 Advancements in healthcare infrastructure and access to innovative treatments in Thailand |
4.3 Market Restraints |
4.3.1 High cost of daratumumab treatment |
4.3.2 Regulatory challenges and approval processes for new drugs in Thailand |
4.3.3 Competition from alternative treatment options for multiple myeloma |
5 Thailand Daratumumab Market Trends |
6 Thailand Daratumumab Market, By Types |
6.1 Thailand Daratumumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Daratumumab Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Thailand Daratumumab Market Revenues & Volume, By Injectable Daratumumab, 2021 - 2031F |
6.1.4 Thailand Daratumumab Market Revenues & Volume, By Daratumumab Biosimilar, 2021 - 2031F |
6.1.5 Thailand Daratumumab Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.1.6 Thailand Daratumumab Market Revenues & Volume, By Oral Daratumumab, 2021 - 2031F |
6.2 Thailand Daratumumab Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Daratumumab Market Revenues & Volume, By Monoclonal Antibody, 2021 - 2031F |
6.2.3 Thailand Daratumumab Market Revenues & Volume, By Biosimilar Technology, 2021 - 2031F |
6.2.4 Thailand Daratumumab Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.5 Thailand Daratumumab Market Revenues & Volume, By Oral Drug Delivery, 2021 - 2031F |
6.3 Thailand Daratumumab Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Thailand Daratumumab Market Revenues & Volume, By Oncologists, 2021 - 2031F |
6.3.3 Thailand Daratumumab Market Revenues & Volume, By Healthcare Providers, 2021 - 2031F |
6.3.4 Thailand Daratumumab Market Revenues & Volume, By Cancer Patients, 2021 - 2031F |
6.3.5 Thailand Daratumumab Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Thailand Daratumumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Thailand Daratumumab Market Revenues & Volume, By Multiple Myeloma Treatment, 2021 - 2031F |
6.4.3 Thailand Daratumumab Market Revenues & Volume, By Cancer Therapy, 2021 - 2031F |
6.4.4 Thailand Daratumumab Market Revenues & Volume, By Co-Therapy with Chemotherapy, 2021 - 2031F |
6.4.5 Thailand Daratumumab Market Revenues & Volume, By Advanced Myeloma Care, 2021 - 2031F |
7 Thailand Daratumumab Market Import-Export Trade Statistics |
7.1 Thailand Daratumumab Market Export to Major Countries |
7.2 Thailand Daratumumab Market Imports from Major Countries |
8 Thailand Daratumumab Market Key Performance Indicators |
8.1 Patient survival rates with daratumumab therapy |
8.2 Adoption rate of daratumumab within the target patient population |
8.3 Number of clinical trials and research studies on daratumumab efficacy in Thailand |
9 Thailand Daratumumab Market - Opportunity Assessment |
9.1 Thailand Daratumumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Thailand Daratumumab Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 Thailand Daratumumab Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Thailand Daratumumab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand Daratumumab Market - Competitive Landscape |
10.1 Thailand Daratumumab Market Revenue Share, By Companies, 2024 |
10.2 Thailand Daratumumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here